December 2024
1. WIDOM CS, Courtney K, Do HH
   Pathways to Homelessness: Childhood Maltreatment and Psychiatric Symptoms Increase Risk of Homelessness.
   Am J Psychiatry. 2024;181:1103-1111.
   

   >> Share

   
   
2. GREY DK, Purcell JB, Buford KN, Schuster MA, et al
   Discrimination Exposure, Neural Reactivity to Stress, and Psychological Distress.
   Am J Psychiatry. 2024;181:1112-1126.
   

   >> Share

   
   October 2024
3. GALLUCCI J, Yu JC, Oliver LD, Nakua H, et al
   Neural Circuitry and Therapeutic Targeting of Depressive Symptoms in Schizophrenia Spectrum Disorders.
   Am J Psychiatry. 2024;181:910-919.
   

   >> Share

   
   
4. HWANG M, Brady R
   Neural Circuitry and Therapeutic Targeting of Depressive Symptoms in Schizophrenia Spectrum Disorders.
   Am J Psychiatry. 2024;181:858-860.
   

   >> Share

   
   September 2024
5. SOARES CN
   Contraception, Intrauterine Systems, and Depression: Can We Spot the Real Perpetrator?
   Am J Psychiatry. 2024;181:789-792.
   

   >> Share

   
   
6. MARTIN DM, Nikolin S
   "Closing the Loop" With Transcranial Electrical Stimulation for Depression.
   Am J Psychiatry. 2024;181:793-794.
   

   >> Share

   
   
7. KASTER TS, Blumberger DM
   Positioning rTMS Within a Sequential Treatment Algorithm of Depression.
   Am J Psychiatry. 2024;181:781-783.
   

   >> Share

   
   
8. KALIN NH
   Depression: Factors Contributing to Risk and Therapeutic Insights.
   Am J Psychiatry. 2024;181:777-780.
   

   >> Share

   
   
9. DALHUISEN I, van Oostrom I, Spijker J, Wijnen B, et al
   rTMS as a Next Step in Antidepressant Nonresponders: A Randomized Comparison With Current Antidepressant Treatment Approaches.
   Am J Psychiatry. 2024;181:806-814.
   

   >> Share

   
   
10. SCHWIPPEL T, Pupillo F, Feldman Z, Walker C, et al
    Closed-Loop Transcranial Alternating Current Stimulation for the Treatment of Major Depressive Disorder: An Open-Label Pilot Study.
    Am J Psychiatry. 2024;181:842-845.
    

    >> Share

    
    
11. HESS EM, Greenstein DK, Hutchinson OL, Zarate CA, et al
    Entactogen Effects of Ketamine: A Reverse-Translational Study.
    Am J Psychiatry. 2024;181:815-823.
    

    >> Share

    
    August 2024
12. SALVATORE JE, Ohlsson H, Sundquist J, Sundquist K, et al
    Peer Social Genetic Effects and the Etiology of Substance Use Disorders, Major Depression, and Anxiety Disorder in a Swedish National Sample.
    Am J Psychiatry. 2024 Aug 7:appiajp20230358. doi: 10.1176/appi.ajp.20230358.
    

    >> Share

    
    July 2024
13. LARSEN SV, Mikkelsen AP, Ozenne B, Munk-Olsen T, et al
    Association Between Intrauterine System Hormone Dosage and Depression Risk.
    Am J Psychiatry. 2024 Jul 10:appiajp20230909. doi: 10.1176/appi.ajp.20230909.
    

    >> Share

    
    
14. POLIMANTI R
    Using Medical Records to Investigate the Genetics of Treatment-Resistant Depression Across Health Care Systems.
    Am J Psychiatry. 2024;181:569-571.
    

    >> Share

    
    
15. AKIKI TJ, Abdallah CG
    Mapping the Depressed Brain Under Stress Using Multimodal Neuroimaging.
    Am J Psychiatry. 2024;181:578-580.
    

    >> Share

    
    
16. ROHDE C, Ostergaard SD, Jefsen OH
    A Nationwide Target Trial Emulation Assessing the Risk of Antidepressant-Induced Mania Among Patients With Bipolar Depression.
    Am J Psychiatry. 2024;181:630-638.
    

    >> Share

    
    
17. JONSSON L, Horbeck E, Primerano A, Song J, et al
    Association of Occupational Dysfunction and Hospital Admissions With Different Polygenic Profiles in Bipolar Disorder.
    Am J Psychiatry. 2024;181:620-629.
    

    >> Share

    
    May 2024
18. KANG J, Castro VM, Ripperger M, Venkatesh S, et al
    Genome-Wide Association Study of Treatment-Resistant Depression: Shared Biology With Metabolic Traits.
    Am J Psychiatry. 2024 May 15:appiajp20230247. doi: 10.1176/appi.ajp.20230247.
    

    >> Share

    
    April 2024
19. BAUM ML, Widge AS, Carpenter LL, McDonald WM, et al
    Pharmacogenomic Clinical Support Tools for the Treatment of Depression.
    Am J Psychiatry. 2024 Apr 30:appiajp20230657. doi: 10.1176/appi.ajp.20230657.
    

    >> Share

    
    
20. IRONSIDE M, Duda JM, Moser AD, Holsen LM, et al
    Association of Lower Rostral Anterior Cingulate GABA+ and Dysregulated Cortisol Stress Response With Altered Functional Connectivity in Young Adults With Lifetime Depression: A Multimodal Imaging Investigation of Trait and State Effects.
    Am J Psychiatry. 2024 Apr 30:appiajp20230382. doi: 10.1176/appi.ajp.20230382.
    

    >> Share

    
    
21. KAVIRAJAN H
    Neglect of Adverse Effects in Treatment Guidelines for Depression.
    Am J Psychiatry. 2024;181:342-345.
    

    >> Share

    
    March 2024
22. STEFFENS DC
    Late-Life Depression, Antidepressant Treatment, and Cognition: The Short Haul and the Long Haul.
    Am J Psychiatry. 2024;181:183-185.
    

    >> Share

    
    
23. PHILLIPS ML
    Multimodal Predictors of Treatment Response in Major Depressive Disorder: Advancing Personalized Medicine in Psychiatry.
    Am J Psychiatry. 2024;181:180-182.
    

    >> Share

    
    
24. POIROT MG, Ruhe HG, Mutsaerts HMM, Maximov II, et al
    Treatment Response Prediction in Major Depressive Disorder Using Multimodal MRI and Clinical Data: Secondary Analysis of a Randomized Clinical Trial.
    Am J Psychiatry. 2024;181:223-233.
    

    >> Share

    
    February 2024
25. AINSWORTH NJ, Marawi T, Maslej MM, Blumberger DM, et al
    Cognitive Outcomes After Antidepressant Pharmacotherapy for Late-Life Depression: A Systematic Review and Meta-Analysis.
    Am J Psychiatry. 2024 Feb 7:appiajp20230392. doi: 10.1176/appi.ajp.20230392.
    

    >> Share

    
    January 2024
26. KALIN NH
    Improving Clinical Outcomes and Informing New Interventions.
    Am J Psychiatry. 2024;181:1-3.
    

    >> Share

    
    
27. WALASZEK A
    Optimizing the Treatment of Late-Life Depression.
    Am J Psychiatry. 2024;181:7-10.
    

    >> Share

    
    
28. RUBINOW DR
    Suicide and the Menstrual Cycle.
    Am J Psychiatry. 2024;181:11-13.
    

    >> Share

    
    
29. BATAIL JV, Feyder MT, Bentzley BS, Williams NR, et al
    An Avenue for Optimization of Theta Burst Stimulation Protocols? Comments on the FOUR-D Randomized Noninferiority Clinical Trial.
    Am J Psychiatry. 2024;181:68-70.
    

    >> Share

    
    December 2023
30. KALIN NH
    Adversity and Resilience, Postpartum Depression, Suicide, and Racial/Ethnic Disparities.
    Am J Psychiatry. 2023;180:859-861.
    

    >> Share

    
    
31. ADAMS JAM, Chandra P, Mehta D
    The First Large GWAS Meta-Analysis for Postpartum Depression.
    Am J Psychiatry. 2023;180:862-864.
    

    >> Share

    
    
32. STOWE ZN
    Perinatal Mental Health: Advances and Opportunities.
    Am J Psychiatry. 2023;180:874-877.
    

    >> Share

    
    October 2023
33. GUINTIVANO J, Byrne EM, Kiewa J, Yao S, et al
    Meta-Analyses of Genome-Wide Association Studies for Postpartum Depression.
    Am J Psychiatry. 2023 Oct 18:appiajp20230053. doi: 10.1176/appi.ajp.20230053.
    

    >> Share

    
    
34. ISHTIAK-AHMED K, Musliner KL, Christensen KS, Mortensen EL, et al
    Real-World Evidence on Clinical Outcomes of Commonly Used Antidepressants in Older Adults Initiating Antidepressants for Depression: A Nationwide Cohort Study in Denmark.
    Am J Psychiatry. 2023 Oct 18:appiajp20230356. doi: 10.1176/appi.ajp.20230356.
    

    >> Share

    
    
35. SHACKMAN AJ, Gee DG
    Maternal Perinatal Stress Associated With Offspring Negative Emotionality, But the Underlying Mechanisms Remain Elusive.
    Am J Psychiatry. 2023;180:708-711.
    

    >> Share

    
    
36. KALIN NH
    Stress, Heritability, and Genetic Factors Influencing Depression, PTSD, and Suicidal Behavior.
    Am J Psychiatry. 2023;180:699-702.
    

    >> Share

    
    
37. LYNALL ME, McIntosh AM
    The Heterogeneity of Depression.
    Am J Psychiatry. 2023;180:703-704.
    

    >> Share

    
    
38. NGUYEN TD, Kowalec K, Pasman J, Larsson H, et al
    Genetic Contribution to the Heterogeneity of Major Depressive Disorder: Evidence From a Sibling-Based Design Using Swedish National Registers.
    Am J Psychiatry. 2023;180:714-722.
    

    >> Share

    
    
39. FARHAT LC, Blakey R, Davey Smith G, Fujita A, et al
    Networks of Neurodevelopmental Traits, Socioenvironmental Factors, Emotional Dysregulation in Childhood, and Depressive Symptoms Across Development in Two U.K. Cohorts.
    Am J Psychiatry. 2023;180:755-765.
    

    >> Share

    
    
40. CHATZINAKOS C, Pernia CD, Morrison FG, Iatrou A, et al
    Single-Nucleus Transcriptome Profiling of Dorsolateral Prefrontal Cortex: Mechanistic Roles for Neuronal Gene Expression, Including the 17q21.31 Locus, in PTSD Stress Response.
    Am J Psychiatry. 2023;180:739-754.
    

    >> Share

    
    
41. DOCHERTY AR, Mullins N, Ashley-Koch AE, Qin X, et al
    GWAS Meta-Analysis of Suicide Attempt: Identification of 12 Genome-Wide Significant Loci and Implication of Genetic Risks for Specific Health Factors.
    Am J Psychiatry. 2023;180:723-738.
    

    >> Share

    
    September 2023
42. PINE DS
    Zuranolone Treatment for Depression: Steady Progress in Mechanism-Focused Therapeutics?
    Am J Psychiatry. 2023;180:631-633.
    

    >> Share

    
    
43. KALIN NH
    Seeking New Solutions Addressing Structural Racism, Childhood Trauma, Suicidal Behaviors Across Sexual Orientations, and Postpartum Depression.
    Am J Psychiatry. 2023;180:625-628.
    

    >> Share

    
    
44. CLAYTON AH, Lasser R, Parikh SV, Iosifescu DV, et al
    Zuranolone for the Treatment of Adults With Major Depressive Disorder: A Randomized, Placebo-Controlled Phase 3 Trial.
    Am J Psychiatry. 2023;180:676-684.
    

    >> Share

    
    July 2023
45. DELIGIANNIDIS KM, Meltzer-Brody S, Maximos B, Peeper EQ, et al
    Zuranolone for the Treatment of Postpartum Depression.
    Am J Psychiatry. 2023 Jul 26:appiajp20220785. doi: 10.1176/appi.ajp.20220785.
    

    >> Share

    
    
46. JESTER DJ, Kohn JN, Tibirica L, Thomas ML, et al
    Differences in Social Determinants of Health Underlie Racial/Ethnic Disparities in Psychological Health and Well-Being: Study of 11,143 Older Adults.
    Am J Psychiatry. 2023;180:483-494.
    

    >> Share

    
    April 2023
47. BIERNACKA JM
    Do Polygenic Scores Inform Psychiatric Disease Risk After Considering Family History?
    Am J Psychiatry. 2023;180:256-258.
    

    >> Share

    
    March 2023
48. ELBAU IG, Lynch CJ, Downar J, Vila-Rodriguez F, et al
    Functional Connectivity Mapping for rTMS Target Selection in Depression.
    Am J Psychiatry. 2023;180:230-240.
    

    >> Share

    
    
49. THASE ME
    A New Option for Depressed Patients Who Do Not Respond to Antidepressant Medications.
    Am J Psychiatry. 2023;180:188-189.
    

    >> Share

    
    
50. KALIN NH
    Insights and Advances Into Treatments for Major Depression.
    Am J Psychiatry. 2023;180:173-176.
    

    >> Share

    
    
51. JHA MK, Mathew SJ
    Pharmacotherapies for Treatment-Resistant Depression: How Antipsychotics Fit in the Rapidly Evolving Therapeutic Landscape.
    Am J Psychiatry. 2023;180:190-199.
    

    >> Share

    
    
52. NUNES EV
    Alcohol and the Etiology of Depression.
    Am J Psychiatry. 2023;180:179-181.
    

    >> Share

    
    
53. SACHS GS, Yeung PP, Rekeda L, Khan A, et al
    Adjunctive Cariprazine for the Treatment of Patients With Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study.
    Am J Psychiatry. 2023;180:241-251.
    

    >> Share

    
    
54. DUNLOP BW, Cha J, Choi KS, Rajendra JK, et al
    Shared and Unique Changes in Brain Connectivity Among Depressed Patients After Remission With Pharmacotherapy Versus Psychotherapy.
    Am J Psychiatry. 2023;180:218-229.
    

    >> Share

    
    
55. HASSERIS S, Albinana C, Vilhjalmsson BJ, Mortensen PB, et al
    Polygenic Risk and Episode Polarity Among Individuals With Bipolar Disorder.
    Am J Psychiatry. 2023;180:200-208.
    

    >> Share

    
    February 2023
56. BELSKY DW, Domingue BW
    Progress and Challenges in GxE Research on Depression.
    Am J Psychiatry. 2023;180:111-113.
    

    >> Share

    
    January 2023
57. VISONTAY R, Mewton L, Slade T, Aris IM, et al
    Moderate Alcohol Consumption and Depression: A Marginal Structural Model Approach Promoting Causal Inference.
    Am J Psychiatry. 2023 Jan 18:appiajp22010043. doi: 10.1176/appi.ajp.22010043.
    

    >> Share

    
    
58. CLEARY JL, Fang Y, Zahodne LB, Bohnert ASB, et al
    Polygenic Risk and Social Support in Predicting Depression Under Stress.
    Am J Psychiatry. 2023 Jan 11:appiajp21111100. doi: 10.1176/appi.ajp.21111100.
    

    >> Share

    
    December 2022
59. BARBER G, Nemeroff CB, Siegel S
    A Case of Prolonged Mania, Psychosis, and Severe Depression After Psilocybin Use: Implications of Increased Psychedelic Drug Availability.
    Am J Psychiatry. 2022;179:892-896.
    

    >> Share

    
    
60. SCHATZBERG AF
    An Innovative Approach to Extending the Antidepressant Effects of Intravenous Ketamine in Major Depression.
    Am J Psychiatry. 2022;179:890-891.
    

    >> Share

    
    
61. PRICE RB, Spotts C, Panny B, Griffo A, et al
    A Novel, Brief, Fully Automated Intervention to Extend the Antidepressant Effect of a Single Ketamine Infusion: A Randomized Clinical Trial.
    Am J Psychiatry. 2022;179:959-968.
    

    >> Share

    
    November 2022
62. JESPERSEN A, Yilmaz Z, Vilhjalmsson BJ
    Harnessing the Power of Population Cohorts to Study the Relationship Between Endocrine-Metabolic Disorders and Depression.
    Am J Psychiatry. 2022;179:788-790.
    

    >> Share

    
    
63. URSANO RJ, Stein MB
    From Soldier's Heart to Shared Genetic Risk: PTSD and Cardiovascular Disease.
    Am J Psychiatry. 2022;179:785-787.
    

    >> Share

    
    
64. SELIGOWSKI AV, Misganaw B, Duffy LA, Ressler KJ, et al
    Leveraging Large-Scale Genetics of PTSD and Cardiovascular Disease to Demonstrate Robust Shared Risk and Improve Risk Prediction Accuracy.
    Am J Psychiatry. 2022;179:814-823.
    

    >> Share

    
    
65. SIGSTROM R, Kowalec K, Jonsson L, Clements CC, et al
    Association Between Polygenic Risk Scores and Outcome of ECT.
    Am J Psychiatry. 2022;179:844-852.
    

    >> Share

    
    September 2022
66. LEONE M, Kuja-Halkola R, Leval A, Butwicka A, et al
    Genetic and Environmental Contribution to the Co-Occurrence of Endocrine-Metabolic Disorders and Depression: A Nationwide Swedish Study of Siblings.
    Am J Psychiatry. 2022 Sep 21:appiajp21090954. doi: 10.1176/appi.ajp.21090954.
    

    >> Share

    
    
67. MARKOWITZ JC, Wright JH, Peeters F, Thase ME, et al
    Psychotherapy's Role for Treatment-Resistant Depression: Reply to Bartova et al.
    Am J Psychiatry. 2022;179:688.
    

    >> Share

    
    
68. RICE F
    The Intergenerational Transmission of Anxiety Disorders and Major Depression.
    Am J Psychiatry. 2022;179:596-598.
    

    >> Share

    
    
69. DURGAM S, Chen R, Calabrese JR, Sachs GS, et al
    Treatments for Depression in Bipolar II Disorder.
    Am J Psychiatry. 2022;179:688-690.
    

    >> Share

    
    
70. BARTOVA L, Fugger G, Dold M, Kautzky A, et al
    Psychotherapy's Role for Treatment-Resistant Depression?
    Am J Psychiatry. 2022;179:687.
    

    >> Share

    
    
71. OSTACHER M
    Treatments for Depression in Bipolar II Disorder: Reply to Durgam et al.
    Am J Psychiatry. 2022;179:690.
    

    >> Share

    
    
72. KENDLER KS, Abrahamsson L, Ohlsson H, Sundquist J, et al
    An Extended Swedish Adoption Study of Anxiety Disorder and Its Cross-Generational Familial Relationship With Major Depression.
    Am J Psychiatry. 2022;179:640-649.
    

    >> Share

    
    
73. JAFFE AE, Tao R, Page SC, Maynard KR, et al
    Decoding Shared Versus Divergent Transcriptomic Signatures Across Cortico-Amygdala Circuitry in PTSD and Depressive Disorders.
    Am J Psychiatry. 2022;179:673-686.
    

    >> Share

    
    July 2022
74. HARVEY PD
    Digital Therapeutics to Enhance Cognition in Major Depression: How Can We Make the Cognitive Gains Translate Into Functional Improvements?
    Am J Psychiatry. 2022;179:445-447.
    

    >> Share

    
    
75. FERRARELLI F
    Is Neuroplasticity Key to Treatment Response in Depression? Maybe So.
    Am J Psychiatry. 2022;179:451-453.
    

    >> Share

    
    
76. PIZZAGALLI DA
    Toward a Better Understanding of the Mechanisms and Pathophysiology of Anhedonia: Are We Ready for Translation?
    Am J Psychiatry. 2022;179:458-469.
    

    >> Share

    
    
77. TAMM S, Harmer CJ, Schiel J, Holub F, et al
    No Association Between Amygdala Responses to Negative Faces and Depressive Symptoms: Cross-Sectional Data from 28,638 Individuals in the UK Biobank Cohort.
    Am J Psychiatry. 2022;179:509-513.
    

    >> Share

    
    
78. KALIN NH
    Neuroscientific Advances Supporting New Treatments for Major Depression.
    Am J Psychiatry. 2022;179:441-444.
    

    >> Share

    
    
79. GROGANS SE, Fox AS, Shackman AJ
    The Amygdala and Depression: A Sober Reconsideration.
    Am J Psychiatry. 2022;179:454-457.
    

    >> Share

    
    
80. TABUTEAU H, Jones A, Anderson A, Jacobson M, et al
    Effect of AXS-05 (Dextromethorphan-Bupropion) in Major Depressive Disorder: A Randomized Double-Blind Controlled Trial.
    Am J Psychiatry. 2022;179:490-499.
    

    >> Share

    
    June 2022
81. HANKERSON SH, Moise N, Wilson D, Waller BY, et al
    The Intergenerational Impact of Structural Racism and Cumulative Trauma on Depression.
    Am J Psychiatry. 2022;179:434-440.
    

    >> Share

    
    May 2022
82. GE R, Humaira A, Gregory E, Alamian G, et al
    Predictive Value of Acute Neuroplastic Response to rTMS in Treatment Outcome in Depression: A Concurrent TMS-fMRI Trial.
    Am J Psychiatry. 2022 May 18:appiajp21050541. doi: 10.1176/appi.ajp.21050541.
    

    >> Share

    
    
83. PAN PM, Sato JR, Paillere Martinot ML, Martinot JL, et al
    Longitudinal Trajectory of the Link Between Ventral Striatum and Depression in Adolescence.
    Am J Psychiatry. 2022 May 18:appiajp20081180. doi: 10.1176/appi.ajp.20081180.
    

    >> Share

    
    April 2022
84. KEEFE RSE, Canadas E, Farlow D, Etkin A, et al
    Digital Intervention for Cognitive Deficits in Major Depression: A Randomized Controlled Trial to Assess Efficacy and Safety in Adults.
    Am J Psychiatry. 2022 Apr 12:appiajp21020125. doi: 10.1176/appi.ajp.21020125.
    

    >> Share

    
    February 2022
85. MARKOWITZ JC, Wright JH, Peeters F, Thase ME, et al
    The Neglected Role of Psychotherapy for Treatment-Resistant Depression.
    Am J Psychiatry. 2022;179:90-93.
    

    >> Share

    
    
86. WEISSMAN CR, Daskalakis ZJ
    Accelerated Intermittent Theta Burst Stimulation: Expediting and Enhancing Treatment Outcomes in Treatment-Resistant Depression.
    Am J Psychiatry. 2022;179:85-87.
    

    >> Share

    
    
87. NEMEROFF CB
    Back to the Future: Esmethadone, the (Maybe) Nonopiate Opiate, and Depression.
    Am J Psychiatry. 2022;179:83-84.
    

    >> Share

    
    
88. FAVA M, Stahl S, Pani L, De Martin S, et al
    REL-1017 (Esmethadone) as Adjunctive Treatment in Patients With Major Depressive Disorder: A Phase 2a Randomized Double-Blind Trial.
    Am J Psychiatry. 2022;179:122-131.
    

    >> Share

    
    
89. COLE EJ, Phillips AL, Bentzley BS, Stimpson KH, et al
    Stanford Neuromodulation Therapy (SNT): A Double-Blind Randomized Controlled Trial.
    Am J Psychiatry. 2022;179:132-141.
    

    >> Share

    
    January 2022
90. KVARTA M, Ma Y, Hong LE
    Comment on "Elevated C-Reactive Protein in Patients With Depression, Independent of Genetic, Health, and Psychosocial Factors: Results From the UK Biobank".
    Am J Psychiatry. 2022;179:73.
    

    >> Share

    
    December 2021
91. MCINTYRE RS
    Ketamine and Esketamine for Treatment-Resistant Depression: Response to Reus, Mattes, and Schatzberg.
    Am J Psychiatry. 2021;178:1130-1132.
    

    >> Share

    
    
92. PARIANTE CM
    Increased Inflammation in Depression: A Little in All, or a Lot in a Few?
    Am J Psychiatry. 2021;178:1077-1079.
    

    >> Share

    
    
93. KALIN NH
    New Insights Into Major Depression and the Treatment of Bipolar Depression.
    Am J Psychiatry. 2021;178:1071-1074.
    

    >> Share

    
    
94. CONROY SK, Holtzheimer PE
    Neuromodulation Strategies for the Treatment of Depression.
    Am J Psychiatry. 2021;178:1082-1088.
    

    >> Share

    
    
95. OSTACHER MJ
    Slowly Working Toward More Treatments for Depression in Bipolar II Disorder.
    Am J Psychiatry. 2021;178:1075-1076.
    

    >> Share

    
    
96. SCHATZBERG AF
    Mechanisms of Action of Ketamine and Esketamine.
    Am J Psychiatry. 2021;178:1130.
    

    >> Share

    
    
97. REUS VI
    Recommendations for the Usage of Ketamine and Esketamine.
    Am J Psychiatry. 2021;178:1129.
    

    >> Share

    
    
98. ZHUKOVSKY P, Anderson JAE, Coughlan G, Mulsant BH, et al
    Coordinate-Based Network Mapping of Brain Structure in Major Depressive Disorder in Younger and Older Adults: A Systematic Review and Meta-Analysis.
    Am J Psychiatry. 2021;178:1119-1128.
    

    >> Share

    
    
99. CALABRESE JR, Durgam S, Satlin A, Vanover KE, et al
    Efficacy and Safety of Lumateperone for Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder: A Phase 3 Randomized Placebo-Controlled Trial.
    Am J Psychiatry. 2021;178:1098-1106.
    

    >> Share

    
    November 2021
100. KEDING TJ, Heyn SA, Russell JD, Zhu X, et al
     Differential Patterns of Delayed Emotion Circuit Maturation in Abused Girls With and Without Internalizing Psychopathology.
     Am J Psychiatry. 2021;178:1026-1036.
     

     >> Share

     
     October 2021
101. FRANK P, Jokela M, Batty GD, Cadar D, et al
     Association Between Systemic Inflammation and Individual Symptoms of Depression: A Pooled Analysis of 15 Population-Based Cohort Studies.
     Am J Psychiatry. 2021 Oct 14:appiajp202120121776.
     

     >> Share

     
     
102. KALIN NH
     Depression and Schizophrenia: Sleep, Medical Risk Factors, Biomarkers, and Treatment.
     Am J Psychiatry. 2021;178:881-884.
     

     >> Share

     
     
103. PLANTE DT
     The Evolving Nexus of Sleep and Depression.
     Am J Psychiatry. 2021;178:896-902.
     

     >> Share

     
     
104. MCINTYRE RS
     Surrogate Markers of Insulin Resistance in Predicting Major Depressive Disorder: Metabolism Metastasizes to the Brain.
     Am J Psychiatry. 2021;178:885-887.
     

     >> Share

     
     
105. WATSON KT, Simard JF, Henderson VW, Nutkiewicz L, et al
     Incident Major Depressive Disorder Predicted by Three Measures of Insulin Resistance: A Dutch Cohort Study.
     Am J Psychiatry. 2021;178:914-920.
     

     >> Share

     
     July 2021
106. ROXAS N, Ahuja C, Isom J, Wilkinson ST, et al
     A Potential Case of Acute Ketamine Withdrawal: Clinical Implications for the Treatment of Refractory Depression.
     Am J Psychiatry. 2021;178:588-591.
     

     >> Share

     
     June 2021
107. PENNINX BWJH
     Using the Power of a Giant Wisely: Confirming Inflammation in Depression.
     Am J Psychiatry. 2021;178:480-482.
     

     >> Share

     
     
108. KALIN NH
     COVID-19 and Stress-Related Disorders.
     Am J Psychiatry. 2021;178:471-474.
     

     >> Share

     
     
109. RUBINOW DR, Lasser R, Kanes SJ
     Comment on "Understanding the Clinical Effects and Mechanisms of Action of Neurosteroids".
     Am J Psychiatry. 2021;178:572-573.
     

     >> Share

     
     May 2021
110. PITHAROULI MC, Hagenaars SP, Glanville KP, Coleman JRI, et al
     Elevated C-Reactive Protein in Patients With Depression, Independent of Genetic, Health, and Psychosocial Factors: Results From the UK Biobank.
     Am J Psychiatry. 2021 May 14:appiajp202020060947.
     

     >> Share

     
     
111. MAIXNER DF, Weiner R, Reti IM, Hermida AP, et al
     Electroconvulsive Therapy Is an Essential Procedure.
     Am J Psychiatry. 2021;178:381-382.
     

     >> Share

     
     
112. SCHATZBERG AF
     Can Target Engagement Studies Miss Their Targets and Mislead Drug Development?
     Am J Psychiatry. 2021;178:372-374.
     

     >> Share

     
     
113. FERRARELLI F, Phillips ML
     Examining and Modulating Neural Circuits in Psychiatric Disorders With Transcranial Magnetic Stimulation and Electroencephalography: Present Practices and Future Developments.
     Am J Psychiatry. 2021;178:400-413.
     

     >> Share

     
     April 2021
114. KALIN NH
     Anxiety, Depression, and Suicide in Youth.
     Am J Psychiatry. 2021;178:275-279.
     

     >> Share

     
     
115. PARIKH T, Walkup JT
     The Future of Ketamine in the Treatment of Teen Depression.
     Am J Psychiatry. 2021;178:288-289.
     

     >> Share

     
     
116. NEMEROFF CB
     The Trifecta of Misery and Disease Vulnerability: Poverty, Childhood Maltreatment, and Inflammation.
     Am J Psychiatry. 2021;178:282-284.
     

     >> Share

     
     
117. BOELEN PA, Lenferink LIM, Spuij M
     CBT for Prolonged Grief in Children and Adolescents: A Randomized Clinical Trial.
     Am J Psychiatry. 2021;178:294-304.
     

     >> Share

     
     
118. SEQUEIRA SL, Silk JS, Ladouceur CD, Hanson JL, et al
     Association of Neural Reward Circuitry Function With Response to Psychotherapy in Youths With Anxiety Disorders.
     Am J Psychiatry. 2021;178:343-351.
     

     >> Share

     
     
119. BIERMAN KL, Heinrichs BS, Welsh JA, Nix RL, et al
     Reducing Adolescent Psychopathology in Socioeconomically Disadvantaged Children With a Preschool Intervention: A Randomized Controlled Trial.
     Am J Psychiatry. 2021;178:305-312.
     

     >> Share

     
     March 2021
120. MCINTYRE RS, Rosenblat JD, Nemeroff CB, Sanacora G, et al
     Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation.
     Am J Psychiatry. 2021 Mar 17:appiajp202020081251.
     

     >> Share

     
     
121. DWYER JB, Landeros-Weisenberger A, Johnson JA, Londono Tobon A, et al
     Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled Trial.
     Am J Psychiatry. 2021 Mar 3:appiajp202020010018.
     

     >> Share

     
     
122. COSTI S, Morris LS, Kirkwood KA, Hoch M, et al
     Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled Trial.
     Am J Psychiatry. 2021 Mar 3:appiajp202020050653.
     

     >> Share

     
     
123. RUBINOW DR
     One Small Step for PMDD, One Large Step for Affective Disorders.
     Am J Psychiatry. 2021;178:215-217.
     

     >> Share

     
     
124. COMASCO E, Kopp Kallner H, Bixo M, Hirschberg AL, et al
     Ulipristal Acetate for Treatment of Premenstrual Dysphoric Disorder: A Proof-of-Concept Randomized Controlled Trial.
     Am J Psychiatry. 2021;178:256-265.
     

     >> Share

     
     
125. KLEINMAN RA, Schatzberg AF
     Understanding the Clinical Effects and Mechanisms of Action of Neurosteroids.
     Am J Psychiatry. 2021;178:221-223.
     

     >> Share

     
     February 2021
126. SUMMERS RF, Gorrindo T, Hwang S, Aggarwal R, et al
     Psychiatrist Burnout: Response to Schonfeld and Bianchi.
     Am J Psychiatry. 2021;178:204-205.
     

     >> Share

     
     
127. SCHONFELD IS, Bianchi R
     Psychiatrist Burnout.
     Am J Psychiatry. 2021;178:204.
     

     >> Share

     
     
128. FEDER A, Costi S, Rutter SB, Collins AB, et al
     A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder.
     Am J Psychiatry. 2021;178:193-202.
     

     >> Share

     
     January 2021
129. SHMULEWITZ D, Aharonovich E, Witkiewitz K, Anton RF, et al
     The World Health Organization Risk Drinking Levels Measure of Alcohol Consumption: Prevalence and Health Correlates in Nationally Representative Surveys of U.S. Adults, 2001-2002 and 2012-2013.
     Am J Psychiatry. 2021 Jan 21:appiajp202020050610.
     

     >> Share

     
     November 2020
130. SINHA R, Wemm S, Fogelman N, Milivojevic V, et al
     Moderation of Prazosin's Efficacy by Alcohol Withdrawal Symptoms.
     Am J Psychiatry. 2020 Nov 19:appiajp202020050609.
     

     >> Share

     
     October 2020
131. COUGHLIN LN, Pfeiffer P, Ganoczy D, Lin LA, et al
     Quality of Outpatient Depression Treatment in Patients With Comorbid Substance Use Disorder.
     Am J Psychiatry. 2020 Oct 29:appiajp202020040454.
     

     >> Share

     
     
132. MATHEW SJ
     Is Testosterone an Effective Hormonal Therapy for Women With Antidepressant-Resistant Major Depression?
     Am J Psychiatry. 2020;177:891-894.
     

     >> Share

     
     
133. KALIN NH
     Insights Into Suicide and Depression.
     Am J Psychiatry. 2020;177:877-880.
     

     >> Share

     
     
134. HOLMANS PA
     Using Genetics to Increase Specificity of Outcome Prediction in Psychiatric Disorders: Prospects for Progression.
     Am J Psychiatry. 2020;177:884-887.
     

     >> Share

     
     
135. FIRTH J, Wootton RE, Carvalho AF
     Toward Preventive Psychiatry: The Role of Advanced Epidemiological Methods.
     Am J Psychiatry. 2020;177:888-890.
     

     >> Share

     
     
136. SUMMERS RF
     The Elephant in the Room: What Burnout Is and What It Is Not.
     Am J Psychiatry. 2020;177:898-899.
     

     >> Share

     
     
137. MEDINA-RODRIGUEZ EM, Madorma D, O'Connor G, Mason BL, et al
     Identification of a Signaling Mechanism by Which the Microbiome Regulates Th17 Cell-Mediated Depressive-Like Behaviors in Mice.
     Am J Psychiatry. 2020;177:974-990.
     

     >> Share

     
     
138. DICHTEL LE, Carpenter LL, Nyer M, Mischoulon D, et al
     Low-Dose Testosterone Augmentation for Antidepressant-Resistant Major Depressive Disorder in Women: An 8-Week Randomized Placebo-Controlled Study.
     Am J Psychiatry. 2020;177:965-973.
     

     >> Share

     
     August 2020
139. MUELLER SC
     Mental Health Treatment Utilization in Transgender Persons: What We Know and What We Don't Know.
     Am J Psychiatry. 2020;177:657-659.
     

     >> Share

     
     
140. CARPENTER LL, Philip NS
     The Future Is Now? Rapid Advances by Brain Stimulation Innovation.
     Am J Psychiatry. 2020;177:654-656.
     

     >> Share

     
     
141. THASE ME
     Charting Sea Changes in Outpatient Pharmacotherapy of Bipolar Disorder.
     Am J Psychiatry. 2020;177:651-653.
     

     >> Share

     
     
142. DWYER JB, Aftab A, Radhakrishnan R, Widge A, et al
     Hormonal Treatments for Major Depressive Disorder: State of the Art.
     Am J Psychiatry. 2020;177:686-705.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share